Medical Condition News

RSS

St. John Hospital enrolls first patient in Moxy- Drug Coated Balloon trial for PAD

Physicians at St. John Hospital and Medical Center have enrolled the first patient in Michigan in LEVANT2, a global, multicenter, randomized clinical trial evaluating the safety and effectiveness of the Moxy- Drug Coated Balloon for the treatment of peripheral arterial disease.

30 Aug 2011

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

The American Academy of Neurology Foundation is calling on all neurology patients and caregivers to submit a short video to its 2012 Neuro Film Festival, telling their story about why more research is needed into finding cures for brain disorders.

30 Aug 2011

New chemical compounds show promise against set of protein-folding diseases

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin.

30 Aug 2011

Study indicates large gap in use of proven therapies for heart attack or stroke

A global study in 17 countries led by McMaster University researchers has found too few patients are using drugs proven to give significant benefits in warding off a heart attack or stroke.

30 Aug 2011

Study: Social partners can help extend memory

Effective memory is a key ability for independent living in later life, and a new Iowa State University study is among the first to report that social partners can help extend memory.

30 Aug 2011

Researchers demonstrate benefits of 8-week 'Beating Heart Problems' group programme

Researchers from the Heart Research Centre in Melbourne, Australia, have demonstrated the benefits of the 8-week 'Beating Heart Problems' group programme in a randomised controlled trial.

30 Aug 2011

Study finds higher incidence of arrhythmias in elite cross-country skiers

A Swedish study presented at the ESC Congress 2011 today, found a higher incidence of arrhythmias in cross-country skiers with a long history of endurance training.

30 Aug 2011

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

Researchers from Yale University are looking to a virus from the same family as the rabies virus to fight a form of cancer primarily found in children and young adults.

30 Aug 2011

UCLA program helps improve seniors' self-perceived memory

Who hasn't forgotten someone's name, misplaced their glasses or walked into a room and not remembered why they entered? Normal age-related memory decline affects more than half of all seniors, and those over 80 are the most vulnerable.

30 Aug 2011

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

Results from the STOP-VT Study were presented at the ESC Congress 2011 today. This is the first ever multi-center, global, prospective trial to evaluate a Remote Magnetic Navigation system for the treatment of ischemic Ventricular Tachycardia.

30 Aug 2011

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

The Echocardiography and Vascular Laboratory at St. Michael's Hospital has been recognized for its commitment to quality patient care and testing for heart and vascular disease.

30 Aug 2011

Ivabradine reduces heart volume among patients with cardiac insufficiency

As guest speaker at the European Society of Cardiology's Congress currently under way in Paris, Dr. Jean-Claude Tardif, Director of the Montreal Heart Institute's Research Centre and professor of medicine at the Universit- de Montr-al, today presented the results of an analysis demonstrating that ivabradine, a medication used to reduce heart rate, also reduces heart volume (left ventricle) among patients with cardiac insufficiency.

30 Aug 2011

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer.

30 Aug 2011

U-M offers transplantation for patients with bile duct cancer

Robert "Buzz" Gehle thought the itchy rash he was experiencing was a recurrence of an earlier case of shingles. But when his doctor saw he was also jaundiced, he immediately knew there was a problem with Gehle's liver.

30 Aug 2011

Optical treatment strategies to correct peripheral vision may slow progression of myopia

New scientific evidence on how feedback from the eye affects visual development may lead to more effective approaches to treating myopia (nearsightedness) in children, reports a paper in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

29 Aug 2011

Curemark's novel compound CM-182 shows promise for treatment of hyperactivity without sedation

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced today that its compound CM-182 demonstrated positive results for reduction in hyperactivity in mice treated with amphetamines. The mouse model screening was performed by the contract research organization, Cerca Insights.

29 Aug 2011

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Pfizer Inc. has received FDA approval of XALKORI (crizotinib) capsules - the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

29 Aug 2011

Zymeworks, Merck collaborate to develop novel bi-specific antibody therapeutic candidates

Zymeworks Inc. today announced a research collaboration with Merck, known as MSD outside the United States and Canada, around Zymeworks' proprietary Azymetric platform for the development of novel bi-specific antibody therapeutic candidates. Bi-specific antibodies are designed to bind to two different drug targets for broad use in clinical applications such as oncology or autoimmune disease.

29 Aug 2011

New insights into Lafora disease

Short-term energy storage in animal cells is usually achieved through the accumulation of glucose, in the form of long and branched chains, known as glycogen. But when this accumulation happens in neurons it is fatal, causing them to degenerate. This neuronal deterioration and death associated with glycogen accumulation is the hallmark of an extremely rare and progressive type of epilepsy known as Lafora disease (LD).

29 Aug 2011

Bioness announces commercial release of NESS L300 Plus System

Bioness Inc., today announced the commercial release of its NESS L300 Plus System. Cleared by the U.S. Food and Drug Administration (FDA) earlier this year, the L300 Plus combines the award winning NESS L300 Foot Drop System with a thigh cuff to activate even more of the nerves and muscles in the leg for greater control while walking.

29 Aug 2011

Medical Condition News

St. John Hospital enrolls first patient in Moxy- Drug Coated Balloon trial for PAD

AAN calls on all neurology patients, caregivers to participate in 2012 Neuro Film Festival

New chemical compounds show promise against set of protein-folding diseases

Study indicates large gap in use of proven therapies for heart attack or stroke

Study: Social partners can help extend memory

Researchers demonstrate benefits of 8-week 'Beating Heart Problems' group programme

Study finds higher incidence of arrhythmias in elite cross-country skiers

Researchers investigate potential of vesicular stomatitis virus against soft tissue sarcomas

UCLA program helps improve seniors' self-perceived memory

Clinical trial to evaluate RMN system for treatment of ischemic Ventricular Tachycardia

St. Michael's Echocardiography and Vascular Laboratory receives ICAEL accreditation

Ivabradine reduces heart volume among patients with cardiac insufficiency

Magnetic resonance imaging may predict survival in patients with advanced rectal cancer

U-M offers transplantation for patients with bile duct cancer

Optical treatment strategies to correct peripheral vision may slow progression of myopia

Curemark's novel compound CM-182 shows promise for treatment of hyperactivity without sedation

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Zymeworks, Merck collaborate to develop novel bi-specific antibody therapeutic candidates

New insights into Lafora disease

Bioness announces commercial release of NESS L300 Plus System

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Neurofilament light as a translational biomarker

Latest News